Sorafenib in Urothelium Cancer of Bladder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01215266
Recruitment Status : Terminated (Slow recruitment)
First Posted : October 6, 2010
Last Update Posted : September 8, 2011
University Hospital, Essen
Information provided by (Responsible Party):
Association of Urologic Oncology (AUO)

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2011
  Actual Study Completion Date : June 2011